MediFind found 292 doctor with experience in WT1-Related Wilms Tumor Syndromes near Cambridge, MA. Of these, 227 are Experienced, 39 are Advanced and 26 are Distinguished.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
David Mcdermott is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Mcdermott is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is currently accepting new patients.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Stefan Balan is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Balan is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Balan is currently accepting new patients.
James Mier is an Oncologist in Boston, Massachusetts. Dr. Mier is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Olga Brook is a Radiologist and an Interventional Radiologist in Boston, Massachusetts. Dr. Brook is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Familial Pancreatic Cancer, Lung Cancer, WT1-Related Wilms Tumor Syndromes, Liver Embolization, and Penectomy.
Massachusetts General Physicians Organization Inc
Douglas Dahl is an Urologist in Boston, Massachusetts. Dr. Dahl is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Dahl is currently accepting new patients.
Massachusetts General Physicians Organization Inc
Adam Feldman is an Urologist in Boston, Massachusetts. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Urothelial Cancer, Nephrectomy, and Cystectomy. Dr. Feldman is currently accepting new patients.
The General Hospital Corporation
Marc Michaelson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Michaelson is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Orchiectomy, and Nephrectomy. Dr. Michaelson is currently accepting new patients.
Massachusetts General Physicians Organization Inc
Ronald Arellano is an Interventional Radiologist and a Radiologist in Boston, Massachusetts. Dr. Arellano is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Fibrolamellar Carcinoma, Ascites, Gastrostomy, and Liver Embolization.
Massachusetts General Physicians Organization Inc
Raul Uppot is a Radiologist and an Interventional Radiologist in Boston, Massachusetts. Dr. Uppot is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Ascites, WT1-Related Wilms Tumor Syndromes, Cardiac Ablation, and Gastrostomy.
Massachusetts General Physicians Organization Inc
Xin Gao is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Gao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), and Colonoscopy. Dr. Gao is currently accepting new patients.
Peter Hahn is a Radiologist in Boston, Massachusetts. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Visceromegaly, Boils, WT1-Related Wilms Tumor Syndromes, and Muscle Invasive Bladder Cancer.
Dana-Farber Cancer Institute, Inc.
Bradley Mcgregor is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Mcgregor is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Muscle Invasive Bladder Cancer, Tissue Biopsy, and Nephrectomy. Dr. Mcgregor is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Wenxin Xu is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Xu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Prostate Cancer, and Nephrectomy. Dr. Xu is currently accepting new patients.
Lauren Harshman is an Oncologist in Boston, Massachusetts. Dr. Harshman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Lymphadenectomy.
Dana-Farber Cancer Institute, Inc.
Atish Choudhury is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Choudhury is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, and Prostatectomy. Dr. Choudhury is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Thomas O'connor is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. O'connor is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome.
Brigham And Womens Physicians Organization Inc
Kemal Tuncali is a Radiologist in Boston, Massachusetts. Dr. Tuncali is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Ureterocele, Prostatectomy, and Liver Embolization.
Brigham And Womens Physicians Organization Inc
Paul Shyn is a Radiologist and a Neuroradiologist in Boston, Massachusetts. Dr. Shyn is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Familial Colorectal Cancer, Cardiac Ablation, and Liver Embolization.
Brigham And Womens Physicians Organization Inc
Steven Chang is an Urologist in Boston, Massachusetts. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Ureterocele, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Chang is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Graeme Steele is an Urologist in Boston, Massachusetts. Dr. Steele is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Muscle Invasive Bladder Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Vasectomy, and Orchiectomy. Dr. Steele is currently accepting new patients.
Last Updated: 10/30/2025
